Albert Kildani | executive |
Stephen Davis | executive |
Brendan Teehan | executive |
Mark Schneyer | executive |
Tessa Romero | analyst |
Ritu Baral | analyst |
Gregory Renza | analyst |
Ami Fadia | analyst |
Yatin Suneja | analyst |
David Hoang | analyst |
Joel Beatty | analyst |
Ashwani Verma | analyst |
Marc Goodman | analyst |
Sumant Kulkarni | analyst |
Uy Ear | analyst |
Good day, everyone, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals First Quarter 2024 Financial Results and Operating Overview Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to Al Kildani, Senior Vice President of Investor Relations and Corporate Communications. Please proceed.